2,012
Participants
Start Date
March 27, 2023
Primary Completion Date
May 15, 2026
Study Completion Date
May 15, 2026
Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1)
Drop counts of nOPV vaccine will be varied to achieve approximately 10\^5.5, 10\^6.0, 10\^6.5 CCID50 or 10\^7.0, 10\^7.5 dose levels.
Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1)
The Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 control and challenge vaccine (mOPV1) contains ≥ 10\^6.0 CCID50 per 0.1 mL (2 drops) dose.
RECRUITING
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka
Collaborators (1)
Bill and Melinda Gates Foundation
OTHER
PT Bio Farma
INDUSTRY
Centers for Disease Control and Prevention
FED
DiagnoSearch Life Sciences Pvt. Ltd.
UNKNOWN
PATH
OTHER